These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Is skeletal alkaline phosphatase a valid staging marker in detection of osteoblastic skeletal metastases of prostate carcinoma?]. Wirtz DC; Wolff JM; Ittel TH; Jakse G; Niethard FU Z Orthop Ihre Grenzgeb; 1998; 136(3):255-9. PubMed ID: 9736988 [TBL] [Abstract][Full Text] [Related]
23. [Predictive factors for bone metastases of prostate cancer]. Chen YH; Nie P; Jiang W; Zhao SJ; Zhang Z; Lin HX; Li MY; Liu YQ; Li PH; Zhu XS Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):205-9. PubMed ID: 26922017 [TBL] [Abstract][Full Text] [Related]
24. [Evaluation of two serum isoenzyme phosphatases as bone metastasis markers]. Desoize B; Pourny C; Amico S; Larbre H; Jardillier JC Bull Cancer; 1990; 77(12):1211-21. PubMed ID: 2081281 [TBL] [Abstract][Full Text] [Related]
25. Higher prostate-specific antigen levels predict improved survival in patients with hormone-refractory prostate cancer who have skeletal metastases and normal serum alkaline phosphatase. Xie W; Nakabayashi M; Regan MM; Oh WK Cancer; 2007 Dec; 110(12):2709-15. PubMed ID: 17960608 [TBL] [Abstract][Full Text] [Related]
26. Alkaline phosphatase isoenzyme patterns in malignant disease. Van Hoof VO; Van Oosterom AT; Lepoutre LG; De Broe ME Clin Chem; 1992 Dec; 38(12):2546-51. PubMed ID: 1458597 [TBL] [Abstract][Full Text] [Related]
27. Which patients with prostatic carcinoma require a staging bone scan? Kemp PM; Maguire GA; Bird NJ Br J Urol; 1997 Apr; 79(4):611-4. PubMed ID: 9126094 [TBL] [Abstract][Full Text] [Related]
28. Prognostic value of alkaline phosphatase flare in patients with metastatic prostate cancer treated with endocrine therapy. Nakashima J; Ozu C; Nishiyama T; Oya M; Ohigashi T; Asakura H; Tachibana M; Murai M Urology; 2000 Nov; 56(5):843-7. PubMed ID: 11068314 [TBL] [Abstract][Full Text] [Related]
29. Changes in prostate-specific antigen, markers of bone metabolism and bone scans after treatment with radium-223. Nome R; Hernes E; Bogsrud TV; Bjøro T; Fosså SD Scand J Urol; 2015 Jun; 49(3):211-7. PubMed ID: 25515952 [TBL] [Abstract][Full Text] [Related]
30. [Levels of prostate-specific antigen, acid phosphatase, alkaline phosphatase and pain in the prediction of bone metastases in patients with newly diagnosed prostatic carcinoma]. Kliment J; Eliás B; Svihra J Rozhl Chir; 1994 Sep; 73(6):300-2. PubMed ID: 7536351 [TBL] [Abstract][Full Text] [Related]
31. Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Nakashima J; Tachibana M; Horiguchi Y; Oya M; Ohigashi T; Asakura H; Murai M Clin Cancer Res; 2000 Jul; 6(7):2702-6. PubMed ID: 10914713 [TBL] [Abstract][Full Text] [Related]
32. An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer. Gohji K; Nomi M; Kizaki T; Morisue K; Okamoto M; Takenaka A; Fujii A Br J Urol; 1997 Apr; 79(4):602-7. PubMed ID: 9126092 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of skeletal alkaline phosphatase and prostate-specific antigen in the diagnosis of bone metastasis in cancer of the prostate. Wolff JM; Ittel T; Borchers H; Brauers A; Jakse G Urol Int; 1998 Oct; 61(1):12-6. PubMed ID: 9792976 [TBL] [Abstract][Full Text] [Related]
34. Insulin-like growth factor-binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia. Ho PJ; Baxter RC Clin Endocrinol (Oxf); 1997 Feb; 46(2):145-54. PubMed ID: 9135695 [TBL] [Abstract][Full Text] [Related]
35. [Analysis of relation between types of bony metastasis and PSA and tumor differentiation of prostate cancer]. Wang JW; Man LB; Huang GL; Li GZ; He F; Wang HD; Wang H; Liu N Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):956-8. PubMed ID: 20646643 [TBL] [Abstract][Full Text] [Related]
36. Lactate dehydrogenase is a prognostic indicator for prostate cancer patients with bone metastasis. Naruse K; Yamada Y; Aoki S; Taki T; Nakamura K; Tobiume M; Zennami K; Katsuda R; Sai S; Nishio Y; Inoue Y; Noguchi H; Hondai N Hinyokika Kiyo; 2007 May; 53(5):287-92. PubMed ID: 17561711 [TBL] [Abstract][Full Text] [Related]
37. Serum tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of skeletal changes in prostate cancer. Salminen E; Ala-Houhala M; Korpela J; Varpula M; Tiitinen SL; Halleen JM; Väänänen HK Acta Oncol; 2005; 44(7):742-7. PubMed ID: 16227166 [TBL] [Abstract][Full Text] [Related]
38. [Correlation between specific prostatic antigen and findings with total body bone scintigraphy]. López M; Montes De Oca L; Bernardo N; Scorticati C; Suárez P; Bencardino F; De Lasa T; Sotero Falco E; Coimbra F; Scorticati C Arch Esp Urol; 1996 Nov; 49(9):953-5. PubMed ID: 9133295 [TBL] [Abstract][Full Text] [Related]
39. Usefulness of alpha1-antichymotrypsin-PSA complex for predicting bone metastases of prostate cancer. Kikuchi E; Nakashima J; Ishibashi M; Ohigashi T; Oya M; Nakagawa K; Miyajima A; Murai M Urology; 2006 Aug; 68(2):371-5. PubMed ID: 16904455 [TBL] [Abstract][Full Text] [Related]
40. Isoenzymes of alkaline and acid phosphatases as bones metastasis marker in breast cancer patients. Desoize B; Veiler V; Pourny C; Comoe L; Jardillier JC Anticancer Res; 1989; 9(4):1105-9. PubMed ID: 2817792 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]